Company news

IM Cannabis Corp. news in 2022

IM Cannabis Corp.'s news releases, calls and decks from 2022, newest first.

View company

IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split

November 16, 2022

IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

November 13, 2022

IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market

November 6, 2022

IM Cannabis to Report Third Quarter 2022 Financial Results on Monday, November 14 at 9: 00am ET

October 31, 2022

IM Cannabis's Legacy Strain 'Roma' Voted Israel's Favourite Strain of the Month for August 2022

October 25, 2022

IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

October 5, 2022

IM Cannabis Welcomes Two New Members to its Board of Directors

September 12, 2022

IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

August 14, 2022

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9: 00am ET

August 3, 2022

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

May 11, 2022

IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5: 00 p.m. ET

May 4, 2022

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

April 5, 2022

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

March 30, 2022

IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy

March 29, 2022

IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9: 00 a.m. ET

March 28, 2022

IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9: 00 a.m. ET

March 22, 2022

IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel

March 14, 2022

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

March 9, 2022

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

February 7, 2022

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

January 18, 2022

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

January 12, 2022

Calls in 2022

Decks in 2022